CIB heads into its August 10 earnings report having already delivered one print this cycle — the question now is whether the stock can sustain a level that has moved ahead of most analyst targets.
The setup has shifted since the prior preview. CIB closed at $90.25 on Thursday, down nearly 4% on the week and off from the highs above $93 seen around the August 3 report. Goldman Sachs' $98 target — set when Tito Labarta upgraded to Buy on July 28 — remains above the current price, making it the lone bullish outlier on valuation. The consensus mean target is $72.28, a figure the stock blew past weeks ago; that gap deserves a caveat, as several of the underlying targets (JPMorgan at $70, UBS at $72) were set in April and May and have not been refreshed since the stock re-rated. Options positioning has turned modestly more cautious into this second print: the put/call ratio climbed to 0.51 on Thursday, roughly one standard deviation above its 20-day average of 0.44, suggesting options traders added a degree of downside protection on the day of the move lower.
The bear case is essentially valuation-and-gravity. The P/E has expanded to 9.1x and price-to-book reached 1.94x — both up materially over the past 30 days — meaning the stock has re-rated faster than earnings estimates have moved. Bears will note the August 3 print itself produced a 2.7% one-day decline, snapping a pattern of modest beats. The EPS surprise factor score ranks in only the 19th percentile, a notably weak reading that suggests the company has not been a consistent beat-and-raise story. Bulls counter that for a Colombian diversified bank still growing revenue at a double-digit pace, even a fully re-rated 9x P/E is not stretched by regional or global bank standards, and the Goldman Buy remains the freshest and highest-conviction call on the Street.
The lending market offers no signal of directional conviction either way. Borrow availability is extremely loose — the lending pool is essentially untapped, with availability running at the system ceiling — and the cost to borrow has eased back to 0.37% after spiking fourfold over the past month. Short interest in absolute terms is roughly half what it was in late June, with the sharp drop in early July suggesting a prior short cohort covered aggressively into the rally. The ORTEX short score has held steady near 27, well inside neutral territory, and the dividend factor score of 74 points to income-oriented holders providing a stable ownership base beneath the price.
Monday's report will test whether CIB can post results compelling enough to re-anchor the stock above the $90 level — and give the broader analyst community a reason to revisit targets that the price has already left behind.
See the live data behind this article on ORTEX.
Open CIB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
